/DCGO

DocGo Inc

DCGO

$0.35USD↓-3.53%-0.01 today

MARKET CAP

34.9M

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$0 – $0

52W RANGE

$0

$2

AI Summary

Stalk

TrimMedium

DCGO remains entrenched in a Stage 4 decline with a persistent sequence of lower highs and lower lows under declining EMAs. The medium-term bias is Bearish, reinforced by pattern continuation and lack of stabilization, while short-term bounce attempts have failed to reclaim EMAs. Execution timing is unfavorable for selling now, so we Trim exposure on rallies into the 9EMA–20EMA zone and await further confirmation of downtrend continuation.

↑Upgraded 2026 revenue guidance to $300–315M.
↑Non-migrant mobile health revenues jumped 78% YoY.
↓Q2 revenue declined 8.8% YoY to $73.4M.

Full analysis →

Buying

5

institutions

Selling

3

institutions

New Positions

3

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
CA Citadel Advisors LLC Q2 2026	SELL	2.36 M	1.22 M	+-218.99 K	-24.9%	0.00%
RT Renaissance Technologies LLC Q2 2026	BUY	2.25 M	1.16 M	+744.01 K	+22.4%	0.00%
AC Aqr Capital Management LLC Q2 2026	BUY	1.71 M	881.99 K	+973.70 K	+90.7%	0.00%
BI Blackrock, Inc. Q2 2026	SELL	1.45 M	750.44 K	+-4.91 M	-81.3%	0.00%
JC Jpmorgan Chase & Co Q2 2026	SELL	152.26 K	78.58 K	+-47.58 K	-34.5%	0.00%
PA Point72 Asset Management, L.P. Q2 2026	BUYNEW	41.42 K	21.38 K	+41.42 K	+0.0%	0.00%
MM Millennium Management LLC Q2 2026	BUYNEW	19.57 K	10.10 K	+19.57 K	+0.0%	0.00%
BA Balyasny Asset Management L.P. Q2 2026	BUYNEW	13.38 K	6.90 K	+13.38 K	+0.0%	0.00%